Global Creatinine Measurement
Global Creatinine Measurement

Creatinine Measurement Comprehensive Study by Type (Jaffe’s kinetic method, Enzymatic method), Application (Hospitals, Diagnostic Laboratories), Sample (Blood/serum, Urine), Product (Reagents, Kits) Players and Region - Global Market Outlook to 2024

Creatinine Measurement Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Mar 2020 Edition 249 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Creatinine Measurement Market Overview:
Creatinine is synthesized in the human body at the time of muscle contractions. The glomeruli of the kidney removes creatinine from the blood and secretes it into the urine. Creatinine test is a sensitive test employed for measuring the glomerular filtration rate of the kidney. Hence, the creatinine test is extensively used to assess kidney functioning. Presently, direct and automation-ready procedures are gaining popularity in the field of research and drug discovery for measuring creatinine concentration in biological samples.

Market Drivers
  • Increasing Incidence of Renal Disorders
  • Rapid Growth in the Geriatric Population

Market Trend
  • Value Oriented Customers

Restraints
  • Lack of Awareness Among End User Industry
  • Frequently Changing Regulatory Policies

Opportunities
  • Growing Number of Drug Development Initiatives
  • Favorable Government Initiatives to Promote Renal Health

Challenges
  • Identification of Novel Renal Dysfunction Biomarkers
  • Stiff Competition among Major Players


Competitive Landscape:
In Creatinine Measurement Market, it has been observed that most of the companies are upgrading or introducing innovative point of care testing for detection and monitoring of creatinine measurement. They rely on strategies such as mergers & acquisition, product development, geographical expansion, technological innovation and sourcing strategies to enhance their market share.
Some of the key players profiled in the report are F. Hoffmann-la Roche ltd. (Switzerland), Abbott Laboratories (United States), Danaher Corporation (United States), Thermo Fisher Scientific (United States), Siemens Healthineers (Germany), Randox Laboratories (United Kingdom), Pointe Scientific (United States), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories (United States), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (United States) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China). Considering Market by Sample, the sub-segment i.e. Blood/serum will boost the Creatinine Measurement market. Considering Market by Product, the sub-segment i.e. Reagents will boost the Creatinine Measurement market.

“According to the National Center for Biotechnology Information (NCBI) Regulations, The measurement of accurate renal function is vital for the routine care of patients. Determining the renal function status can predict kidney disease progression and prevent toxic drug levels in the body.[2] The glomerular filtration rate (GFR) describes the flow rate of filtered fluid through the kidneys.”

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Creatinine Measurement market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Creatinine Measurement market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Creatinine Measurement Manufacturers, End-Use Market Participants of Different Segments of Creatinine Measurement, Government and Research Organizations, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Jaffe’s kinetic method
  • Enzymatic method
By Application
  • Hospitals
  • Diagnostic Laboratories
By Sample
  • Blood/serum
  • Urine

By Product
  • Reagents
  • Kits

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Renal Disorders
      • 3.2.2. Rapid Growth in the Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Identification of Novel Renal Dysfunction Biomarkers
      • 3.3.2. Stiff Competition among Major Players
    • 3.4. Market Trends
      • 3.4.1. Value Oriented Customers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Creatinine Measurement, by Type, Application, Sample, Product and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Creatinine Measurement (Value)
      • 5.2.1. Global Creatinine Measurement by: Type (Value)
        • 5.2.1.1. Jaffe’s kinetic method
        • 5.2.1.2. Enzymatic method
      • 5.2.2. Global Creatinine Measurement by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Diagnostic Laboratories
      • 5.2.3. Global Creatinine Measurement by: Sample (Value)
        • 5.2.3.1. Blood/serum
        • 5.2.3.2. Urine
      • 5.2.4. Global Creatinine Measurement by: Product (Value)
        • 5.2.4.1. Reagents
        • 5.2.4.2. Kits
      • 5.2.5. Global Creatinine Measurement Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Creatinine Measurement (Price)
      • 5.3.1. Global Creatinine Measurement by: Type (Price)
  • 6. Creatinine Measurement: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. F. Hoffmann-la Roche ltd. (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Danaher Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Thermo Fisher Scientific (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Siemens Healthineers (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Randox Laboratories (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pointe Scientific (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sentinel Ch. Spa. (Italy)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Diasys Diagnostic Systems GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Dialab GmbH (Vienna)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Diazyme Laboratories (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Wako Pure Chemical Industries, Ltd. (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Ortho Clinical Diagnostics (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Creatinine Measurement Sale, by Type, Application, Sample, Product and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Creatinine Measurement (Value)
      • 7.2.1. Global Creatinine Measurement by: Type (Value)
        • 7.2.1.1. Jaffe’s kinetic method
        • 7.2.1.2. Enzymatic method
      • 7.2.2. Global Creatinine Measurement by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Diagnostic Laboratories
      • 7.2.3. Global Creatinine Measurement by: Sample (Value)
        • 7.2.3.1. Blood/serum
        • 7.2.3.2. Urine
      • 7.2.4. Global Creatinine Measurement by: Product (Value)
        • 7.2.4.1. Reagents
        • 7.2.4.2. Kits
      • 7.2.5. Global Creatinine Measurement Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Creatinine Measurement (Price)
      • 7.3.1. Global Creatinine Measurement by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Creatinine Measurement: by Type(USD Million)
  • Table 2. Creatinine Measurement Jaffe’s kinetic method , by Region USD Million (2013-2018)
  • Table 3. Creatinine Measurement Enzymatic method , by Region USD Million (2013-2018)
  • Table 4. Creatinine Measurement: by Application(USD Million)
  • Table 5. Creatinine Measurement Hospitals , by Region USD Million (2013-2018)
  • Table 6. Creatinine Measurement Diagnostic Laboratories , by Region USD Million (2013-2018)
  • Table 7. Creatinine Measurement: by Sample(USD Million)
  • Table 8. Creatinine Measurement Blood/serum , by Region USD Million (2013-2018)
  • Table 9. Creatinine Measurement Urine , by Region USD Million (2013-2018)
  • Table 10. Creatinine Measurement: by Product(USD Million)
  • Table 11. Creatinine Measurement Reagents , by Region USD Million (2013-2018)
  • Table 12. Creatinine Measurement Kits , by Region USD Million (2013-2018)
  • Table 13. South America Creatinine Measurement, by Country USD Million (2013-2018)
  • Table 14. South America Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 15. South America Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 16. South America Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 17. South America Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 18. Brazil Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 19. Brazil Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 20. Brazil Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 21. Brazil Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 22. Argentina Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 23. Argentina Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 24. Argentina Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 25. Argentina Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 26. Rest of South America Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 27. Rest of South America Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 28. Rest of South America Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 29. Rest of South America Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 30. Asia Pacific Creatinine Measurement, by Country USD Million (2013-2018)
  • Table 31. Asia Pacific Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 32. Asia Pacific Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 33. Asia Pacific Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 34. Asia Pacific Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 35. China Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 36. China Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 37. China Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 38. China Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 39. Japan Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 40. Japan Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 41. Japan Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 42. Japan Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 43. India Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 44. India Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 45. India Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 46. India Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 47. South Korea Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 48. South Korea Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 49. South Korea Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 50. South Korea Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 51. Taiwan Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 52. Taiwan Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 53. Taiwan Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 54. Taiwan Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 55. Australia Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 56. Australia Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 57. Australia Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 58. Australia Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 59. Rest of Asia-Pacific Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 60. Rest of Asia-Pacific Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 61. Rest of Asia-Pacific Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 62. Rest of Asia-Pacific Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 63. Europe Creatinine Measurement, by Country USD Million (2013-2018)
  • Table 64. Europe Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 65. Europe Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 66. Europe Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 67. Europe Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 68. Germany Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 69. Germany Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 70. Germany Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 71. Germany Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 72. France Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 73. France Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 74. France Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 75. France Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 76. Italy Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 77. Italy Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 78. Italy Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 79. Italy Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 80. United Kingdom Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 81. United Kingdom Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 82. United Kingdom Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 83. United Kingdom Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 84. Netherlands Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 85. Netherlands Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 86. Netherlands Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 87. Netherlands Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 88. Rest of Europe Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 89. Rest of Europe Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 90. Rest of Europe Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 91. Rest of Europe Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 92. MEA Creatinine Measurement, by Country USD Million (2013-2018)
  • Table 93. MEA Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 94. MEA Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 95. MEA Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 96. MEA Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 97. Middle East Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 98. Middle East Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 99. Middle East Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 100. Middle East Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 101. Africa Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 102. Africa Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 103. Africa Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 104. Africa Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 105. North America Creatinine Measurement, by Country USD Million (2013-2018)
  • Table 106. North America Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 107. North America Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 108. North America Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 109. North America Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 110. United States Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 111. United States Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 112. United States Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 113. United States Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 114. Canada Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 115. Canada Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 116. Canada Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 117. Canada Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 118. Mexico Creatinine Measurement, by Type USD Million (2013-2018)
  • Table 119. Mexico Creatinine Measurement, by Application USD Million (2013-2018)
  • Table 120. Mexico Creatinine Measurement, by Sample USD Million (2013-2018)
  • Table 121. Mexico Creatinine Measurement, by Product USD Million (2013-2018)
  • Table 122. Creatinine Measurement: by Type(USD/Units)
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Creatinine Measurement: by Type(USD Million)
  • Table 138. Creatinine Measurement Jaffe’s kinetic method , by Region USD Million (2019-2024)
  • Table 139. Creatinine Measurement Enzymatic method , by Region USD Million (2019-2024)
  • Table 140. Creatinine Measurement: by Application(USD Million)
  • Table 141. Creatinine Measurement Hospitals , by Region USD Million (2019-2024)
  • Table 142. Creatinine Measurement Diagnostic Laboratories , by Region USD Million (2019-2024)
  • Table 143. Creatinine Measurement: by Sample(USD Million)
  • Table 144. Creatinine Measurement Blood/serum , by Region USD Million (2019-2024)
  • Table 145. Creatinine Measurement Urine , by Region USD Million (2019-2024)
  • Table 146. Creatinine Measurement: by Product(USD Million)
  • Table 147. Creatinine Measurement Reagents , by Region USD Million (2019-2024)
  • Table 148. Creatinine Measurement Kits , by Region USD Million (2019-2024)
  • Table 149. South America Creatinine Measurement, by Country USD Million (2019-2024)
  • Table 150. South America Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 151. South America Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 152. South America Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 153. South America Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 154. Brazil Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 155. Brazil Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 156. Brazil Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 157. Brazil Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 158. Argentina Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 159. Argentina Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 160. Argentina Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 161. Argentina Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 162. Rest of South America Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 163. Rest of South America Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 164. Rest of South America Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 165. Rest of South America Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 166. Asia Pacific Creatinine Measurement, by Country USD Million (2019-2024)
  • Table 167. Asia Pacific Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 168. Asia Pacific Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 169. Asia Pacific Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 170. Asia Pacific Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 171. China Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 172. China Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 173. China Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 174. China Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 175. Japan Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 176. Japan Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 177. Japan Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 178. Japan Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 179. India Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 180. India Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 181. India Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 182. India Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 183. South Korea Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 184. South Korea Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 185. South Korea Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 186. South Korea Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 187. Taiwan Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 188. Taiwan Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 189. Taiwan Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 190. Taiwan Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 191. Australia Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 192. Australia Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 193. Australia Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 194. Australia Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 195. Rest of Asia-Pacific Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 196. Rest of Asia-Pacific Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 197. Rest of Asia-Pacific Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 198. Rest of Asia-Pacific Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 199. Europe Creatinine Measurement, by Country USD Million (2019-2024)
  • Table 200. Europe Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 201. Europe Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 202. Europe Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 203. Europe Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 204. Germany Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 205. Germany Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 206. Germany Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 207. Germany Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 208. France Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 209. France Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 210. France Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 211. France Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 212. Italy Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 213. Italy Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 214. Italy Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 215. Italy Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 216. United Kingdom Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 217. United Kingdom Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 218. United Kingdom Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 219. United Kingdom Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 220. Netherlands Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 221. Netherlands Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 222. Netherlands Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 223. Netherlands Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 224. Rest of Europe Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 225. Rest of Europe Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 226. Rest of Europe Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 227. Rest of Europe Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 228. MEA Creatinine Measurement, by Country USD Million (2019-2024)
  • Table 229. MEA Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 230. MEA Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 231. MEA Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 232. MEA Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 233. Middle East Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 234. Middle East Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 235. Middle East Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 236. Middle East Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 237. Africa Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 238. Africa Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 239. Africa Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 240. Africa Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 241. North America Creatinine Measurement, by Country USD Million (2019-2024)
  • Table 242. North America Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 243. North America Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 244. North America Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 245. North America Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 246. United States Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 247. United States Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 248. United States Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 249. United States Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 250. Canada Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 251. Canada Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 252. Canada Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 253. Canada Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 254. Mexico Creatinine Measurement, by Type USD Million (2019-2024)
  • Table 255. Mexico Creatinine Measurement, by Application USD Million (2019-2024)
  • Table 256. Mexico Creatinine Measurement, by Sample USD Million (2019-2024)
  • Table 257. Mexico Creatinine Measurement, by Product USD Million (2019-2024)
  • Table 258. Creatinine Measurement: by Type(USD/Units)
  • Table 259. Research Programs/Design for This Report
  • Table 260. Key Data Information from Secondary Sources
  • Table 261. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Creatinine Measurement: by Type USD Million (2013-2018)
  • Figure 5. Global Creatinine Measurement: by Application USD Million (2013-2018)
  • Figure 6. Global Creatinine Measurement: by Sample USD Million (2013-2018)
  • Figure 7. Global Creatinine Measurement: by Product USD Million (2013-2018)
  • Figure 8. South America Creatinine Measurement Share (%), by Country
  • Figure 9. Asia Pacific Creatinine Measurement Share (%), by Country
  • Figure 10. Europe Creatinine Measurement Share (%), by Country
  • Figure 11. MEA Creatinine Measurement Share (%), by Country
  • Figure 12. North America Creatinine Measurement Share (%), by Country
  • Figure 13. Global Creatinine Measurement: by Type USD/Units (2013-2018)
  • Figure 14. Global Creatinine Measurement share by Players 2018 (%)
  • Figure 15. Global Creatinine Measurement share by Players (Top 3) 2018(%)
  • Figure 16. Global Creatinine Measurement share by Players (Top 5) 2018(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. F. Hoffmann-la Roche ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. F. Hoffmann-la Roche ltd. (Switzerland) Revenue: by Geography 2018
  • Figure 20. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 22. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 24. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fisher Scientific (United States) Revenue: by Geography 2018
  • Figure 26. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Siemens Healthineers (Germany) Revenue: by Geography 2018
  • Figure 28. Randox Laboratories (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Randox Laboratories (United Kingdom) Revenue: by Geography 2018
  • Figure 30. Pointe Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 31. Pointe Scientific (United States) Revenue: by Geography 2018
  • Figure 32. Sentinel Ch. Spa. (Italy) Revenue, Net Income and Gross profit
  • Figure 33. Sentinel Ch. Spa. (Italy) Revenue: by Geography 2018
  • Figure 34. Diasys Diagnostic Systems GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Diasys Diagnostic Systems GmbH (Germany) Revenue: by Geography 2018
  • Figure 36. Dialab GmbH (Vienna) Revenue, Net Income and Gross profit
  • Figure 37. Dialab GmbH (Vienna) Revenue: by Geography 2018
  • Figure 38. Diazyme Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 39. Diazyme Laboratories (United States) Revenue: by Geography 2018
  • Figure 40. Wako Pure Chemical Industries, Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 41. Wako Pure Chemical Industries, Ltd. (Japan) Revenue: by Geography 2018
  • Figure 42. Ortho Clinical Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 43. Ortho Clinical Diagnostics (United States) Revenue: by Geography 2018
  • Figure 44. Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 45. Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China) Revenue: by Geography 2018
  • Figure 46. Global Creatinine Measurement: by Type USD Million (2019-2024)
  • Figure 47. Global Creatinine Measurement: by Application USD Million (2019-2024)
  • Figure 48. Global Creatinine Measurement: by Sample USD Million (2019-2024)
  • Figure 49. Global Creatinine Measurement: by Product USD Million (2019-2024)
  • Figure 50. South America Creatinine Measurement Share (%), by Country
  • Figure 51. Asia Pacific Creatinine Measurement Share (%), by Country
  • Figure 52. Europe Creatinine Measurement Share (%), by Country
  • Figure 53. MEA Creatinine Measurement Share (%), by Country
  • Figure 54. North America Creatinine Measurement Share (%), by Country
  • Figure 55. Global Creatinine Measurement: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • F. Hoffmann-la Roche ltd. (Switzerland)
  • Abbott Laboratories (United States)
  • Danaher Corporation (United States)
  • Thermo Fisher Scientific (United States)
  • Siemens Healthineers (Germany)
  • Randox Laboratories (United Kingdom)
  • Pointe Scientific (United States)
  • Sentinel Ch. Spa. (Italy)
  • Diasys Diagnostic Systems GmbH (Germany)
  • Dialab GmbH (Vienna)
  • Diazyme Laboratories (United States)
  • Wako Pure Chemical Industries, Ltd. (Japan)
  • Ortho Clinical Diagnostics (United States)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation